The authorization for further reverse stock splits (up to 1:1,000) within three years signals ongoing Nasdaq listing maintenance efforts. Monitor future share price and any board action on executing additional splits, which could further concentrate ownership and signal persistent distress. The 1:7 split already executed does not alter fundamentals.
Price Chart
Executive Summary
C3is Inc. reported results from its 2026 Annual Meeting of Stockholders, including the re-election of directors, ratification of Deloitte as auditors, and shareholder approval for potential future reverse stock splits (up to 1:1,000). The filing also disclosed the previously announced 1-for-7 reverse stock split effected on April 26, 2026, with retroactively adjusted EPS data. The filing is a routine corporate governance update with no new financial performance data.
Key Facts
- Harry N. Vafias and George Xiradakis re-elected as Class III directors for three-year terms expiring in 2029.
- Shareholders ratified Deloitte Certified Public Accountants, S.A. as independent auditors.
- Shareholders approved amendments to effect one or more reverse stock splits of common stock at ratios between 1:2 and 1:1,000, with exact ratio determined by the Board within three years.
- A 1-for-7 reverse stock split was already effected on April 26, 2026, reducing outstanding shares from ~3.8M to ~541,082.
- Retroactively adjusted EPS for fiscal years 2025, 2024, and 2023: basic EPS of $325.49, ($2,460.12), and $335,222.19 respectively; diluted EPS of $27.84, ($2,460.12), and $133,916.72.
Financial Impact
No new financial data; reverse split adjustments are retroactive and do not change economic substance.
Risk Factors
- Potential continued non-compliance with Nasdaq listing requirements if stock price remains low, leading to further reverse splits or delisting.
- Shareholder dilution risk from potential future reverse splits and warrant exercises, as indicated by a complex capital structure with multiple warrant classes.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001193125-26-312537 |
| Document: d19500dex991.htm | 0001193125-26-312537 |
| Document: 0001193125-26-312537-index-headers.html | 0001193125-26-312537 |
| Document: 0001193125-26-312537-index.html | 0001193125-26-312537 |
| Document: 0001193125-26-312537.txt | 0001193125-26-312537 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 19, 2026 7d ago | EFFECT | $0.5490 | awaiting T+60 | — | $0.4734 (+13.77%) |
Oct 19, 2026 7d ago | EFFECT | $0.5490 | awaiting T+60 | — | $0.4734 (+13.77%) |
Oct 19, 2026 7d ago | EFFECT | $0.5490 | awaiting T+60 | — | $0.4734 (+13.77%) |
Oct 5, 2026 20d ago | SC 13G/A | $0.8890 | awaiting T+60 | — | $0.4734 (−46.75%) |
Oct 5, 2026 21d ago | SC 13G/A | $0.8630 | awaiting T+60 | — | $0.4734 (+45.14%) |
Oct 2, 2026 24d ago | SC 13G/A | $0.8310 | awaiting T+60 | — | $0.4734 (+43.03%) |
Sep 29, 2026 27d ago | 6-K | $0.9502 | awaiting T+60 | — | $0.4734 (−50.18%) |
Aug 17, 2026 9w ago | 6-K | $0.0685 | awaiting T+60 | — | $0.4734 (+591.09%) |
Jul 23, 2026 13w ago | F-1/A | $0.5201 $0.0137 | ▲ +97.36% | ▲ +101.09% | $0.4734 (+8.98%) |
Jul 22, 2026 13w ago | 6-K | $0.9620 $0.0133 | ▼ −98.61% | ▼ −102.01% | $0.4734 (−50.79%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers